BMJ: ‘Adding a sulfonylurea to metformin looks safer than switching to one’

BMJ: ‘Adding a sulfonylurea to metformin looks safer than switching to one’

July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk...

Effect of omega-3 or other fatty acids on heart disease is negligible finds Cochrane review

Effect of omega-3 or other fatty acids on heart disease is negligible finds Cochrane review

July 19 2018 Cochrane researchers have published research indicating that omega 3 supplements...

DOACs associated with reduced risk of major bleeding compared to warfarin

DOACs associated with reduced risk of major bleeding compared to warfarin

July 11 2018 Direct oral anticoagulants (DOACs) have been associated with reduced risks of major...

Recorded penicillin allergy associated with increased risk of MRSA and C difficile

Recorded penicillin allergy associated with increased risk of MRSA and C difficile

July 3 2018 People who have a record of penicillin allergy are at an increased risk of developing...

MPS advises of need for better awareness of cauda equina red flag symptoms

MPS advises of need for better awareness of cauda equina red flag symptoms

May 9 2018 The Medical Protection Society is advising doctors of a revision to the NICE Clinical...

  • BMJ: ‘Adding a sulfonylurea to metformin looks safer than switching to one’

    BMJ: ‘Adding a sulfonylurea to metformin looks safer than switching to one’

    Wednesday, 25 July 2018 14:07
  • Effect of omega-3 or other fatty acids on heart disease is negligible finds Cochrane review

    Effect of omega-3 or other fatty acids on heart disease is negligible finds Cochrane review

    Thursday, 19 July 2018 10:36
  • DOACs associated with reduced risk of major bleeding compared to warfarin

    DOACs associated with reduced risk of major bleeding compared to warfarin

    Wednesday, 11 July 2018 13:22
  • Recorded penicillin allergy associated with increased risk of MRSA and C difficile

    Recorded penicillin allergy associated with increased risk of MRSA and C difficile

    Tuesday, 03 July 2018 16:51
  • MPS advises of need for better awareness of cauda equina red flag symptoms

    MPS advises of need for better awareness of cauda equina red flag symptoms

    Wednesday, 09 May 2018 16:01

a doctor consulting young lady imageJuly 4 2018

A new model of care with community pharmacists providing a day’s support each week to a general practice could release 18 million GP appointments nationally.


Outcomes from a pilot scheme in Sheffield has found that “for every day of dedicated community pharmacist support for general practice, one whole session of GP clinical time is created, meaning an additional 25 patients can see their GP every week.”

The scheme was funded through the Prime Minister’s Challenge Fund (PMCF). Basegreen Pharmacy provided dedicated community pharmacy support to the Jaunty Springs Medical Centre, located on a post war housing estate in a Sheffield suburb. The practice has a list size of around 3,600 patients and its population is generally older than the Sheffield and England average.

A report on the scheme has been published by the National Pharmacy Association. It explains: “Through IT integration and a formal partnership agreement between the community pharmacy and the general practice, the community pharmacist was able to undertake appropriate consultations within the community pharmacy setting. 

“Read/write access to the full GP clinical record enabled real time information sharing and allowed the community pharmacist to make full use of their training and knowledge as the NHS medicines expert. Patients were proactively directed towards the pharmacy as a source of care, reducing demand on the practice, and improvements in the patient experience as they were able to be seen more quickly as the community pharmacist was more readily available.”

If rolled out nationally, the scheme could free up 18 million GP appointments a year, said the NPA. 

The NPA’s Chair, Nitin Sodha, said: “On average there is one GP based pharmacist for 30,000 patients, which is nowhere near the scale required to meet current and future demand. In comparison, in Sheffield, the ratio was one community pharmacist for a practice population of 3500, plus the added resource of the pharmacy support staff. 

“Since NHS England has invested heavily in the General Practice Pharmacist Scheme, there is surely a strong justification for investment in pharmacy-based schemes which deliver similar benefits but can cater for many more patients, conveniently and probably at lower cost.”

Mr Sodha has called on NHS England to review this alternative model in more detail and to ensure funding is allocated to support the fuller deployment of the community pharmacy network.

Pharmacist Garry Myers, who is the owner of the pharmacy and an executive partner in the surgery, said without support from the pharmacy the surgery could have closed. 

“The experience of working in this way was beneficial for Basegreen Pharmacy and Jaunty Springs Medical Practice, which may not have survived without this partnership, as it was being overwhelmed by the needs of the local population. But above all, it’s been great for patients in the area, who have benefited from the improved access to medicines support,” he said.  

“We have adopted the successful principle that any patient that could be well-managed by the community pharmacist should be referred there to reduce practice workload, improve the patient experience and encourage positive patient attitudes towards self-care.”

Links:
NPA announcement     
G Myers & J Roach. ‘New Models of Care Supporting General Practice through Community Pharmacy’. July 3 2018.         

Clinical News

July 27 2018 Adolescent boys will be offered the human papilloma virus (HPV) vaccine to protect them from cancer, the Department of Health and Social Care has announced.
July 20 2018 Doctors are being reminded to ensure that any patient or other records which may be relevant to the UK Infected Blood Inquiry are not destroyed. Earlier this month, the Inquiry’s Chair, Sir...